3:06 PM
 | 
Dec 20, 2018
 |  BC Extra  |  Company News

Barrett joins pharma exodus for biotech

Novartis AG (NYSE:NVS; SIX:NOVN) named its third CEO of oncology in 11 months as Elizabeth Barrett joins the exodus of pharma leaders heading to biotech. Barrett said she will become CEO of an undisclosed U.S.-based biotech.

Susanne Schaffert will take the reins as CEO of Novartis Oncology on Jan. 1, less than a year since Barrett left Pfizer Inc. (NYSE:PFE) to fill the role. Barrett replaced Bruno Strigini...

Read the full 318 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >